ID1 and rheumatoid arthritis: However, Adalimumab‐treated mice with anti‐Adalimumab Id Ab exhibited severe arthritis compared with the Adalimumab‐treated mice without anti‐Adalimumab Id Ab, indicating that anti‐Adalimumab Id Ab interfered with Adalimumab and reduced its efficacy for RA therapy.